Global Deferiprone Market Growth 2023-2029

Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.

LPI (LP Information)' newest research report, the “Deferiprone Industry Forecast” looks at past sales and reviews total world Deferiprone sales in 2022, providing a comprehensive analysis by region and market sector of projected Deferiprone sales for 2023 through 2029. With Deferiprone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Deferiprone industry.

This Insight Report provides a comprehensive analysis of the global Deferiprone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Deferiprone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Deferiprone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Deferiprone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Deferiprone.

The global Deferiprone market size is projected to grow from US$ 35 million in 2022 to US$ 45 million in 2029; it is expected to grow at a CAGR of 45 from 2023 to 2029.

Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Those two totally got about 96% market shares.

North America is the largest consumption region of Deferiprone, with a consumption value market share nearly 28%. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24%.

This report presents a comprehensive overview, market shares, and growth opportunities of Deferiprone market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Tablet
    Oral Solution
    Capsule

Segmentation by application
    Transfusional Iron Overload
    NTDT Caused Iron Overload

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Apotex
    Cipla

Key Questions Addressed in this Report
What is the 10-year outlook for the global Deferiprone market?
What factors are driving Deferiprone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Deferiprone market opportunities vary by end market size?
How does Deferiprone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Deferiprone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Deferiprone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Tablet
    Table 4. Major Players of Oral Solution
    Table 5. Major Players of Capsule
    Table 6. Global Deferiprone Sales by Type (2018-2023) & (Kg)
    Table 7. Global Deferiprone Sales Market Share by Type (2018-2023)
    Table 8. Global Deferiprone Revenue by Type (2018-2023) & ($ million)
    Table 9. Global Deferiprone Revenue Market Share by Type (2018-2023)
    Table 10. Global Deferiprone Sale Price by Type (2018-2023) & (USD/g)
    Table 11. Global Deferiprone Sales by Application (2018-2023) & (Kg)
    Table 12. Global Deferiprone Sales Market Share by Application (2018-2023)
    Table 13. Global Deferiprone Revenue by Application (2018-2023)
    Table 14. Global Deferiprone Revenue Market Share by Application (2018-2023)
    Table 15. Global Deferiprone Sale Price by Application (2018-2023) & (USD/g)
    Table 16. Global Deferiprone Sales by Company (2018-2023) & (Kg)
    Table 17. Global Deferiprone Sales Market Share by Company (2018-2023)
    Table 18. Global Deferiprone Revenue by Company (2018-2023) ($ Millions)
    Table 19. Global Deferiprone Revenue Market Share by Company (2018-2023)
    Table 20. Global Deferiprone Sale Price by Company (2018-2023) & (USD/g)
    Table 21. Key Manufacturers Deferiprone Producing Area Distribution and Sales Area
    Table 22. Players Deferiprone Products Offered
    Table 23. Deferiprone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Deferiprone Sales by Geographic Region (2018-2023) & (Kg)
    Table 27. Global Deferiprone Sales Market Share Geographic Region (2018-2023)
    Table 28. Global Deferiprone Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 29. Global Deferiprone Revenue Market Share by Geographic Region (2018-2023)
    Table 30. Global Deferiprone Sales by Country/Region (2018-2023) & (Kg)
    Table 31. Global Deferiprone Sales Market Share by Country/Region (2018-2023)
    Table 32. Global Deferiprone Revenue by Country/Region (2018-2023) & ($ millions)
    Table 33. Global Deferiprone Revenue Market Share by Country/Region (2018-2023)
    Table 34. Americas Deferiprone Sales by Country (2018-2023) & (Kg)
    Table 35. Americas Deferiprone Sales Market Share by Country (2018-2023)
    Table 36. Americas Deferiprone Revenue by Country (2018-2023) & ($ Millions)
    Table 37. Americas Deferiprone Revenue Market Share by Country (2018-2023)
    Table 38. Americas Deferiprone Sales by Type (2018-2023) & (Kg)
    Table 39. Americas Deferiprone Sales by Application (2018-2023) & (Kg)
    Table 40. APAC Deferiprone Sales by Region (2018-2023) & (Kg)
    Table 41. APAC Deferiprone Sales Market Share by Region (2018-2023)
    Table 42. APAC Deferiprone Revenue by Region (2018-2023) & ($ Millions)
    Table 43. APAC Deferiprone Revenue Market Share by Region (2018-2023)
    Table 44. APAC Deferiprone Sales by Type (2018-2023) & (Kg)
    Table 45. APAC Deferiprone Sales by Application (2018-2023) & (Kg)
    Table 46. Europe Deferiprone Sales by Country (2018-2023) & (Kg)
    Table 47. Europe Deferiprone Sales Market Share by Country (2018-2023)
    Table 48. Europe Deferiprone Revenue by Country (2018-2023) & ($ Millions)
    Table 49. Europe Deferiprone Revenue Market Share by Country (2018-2023)
    Table 50. Europe Deferiprone Sales by Type (2018-2023) & (Kg)
    Table 51. Europe Deferiprone Sales by Application (2018-2023) & (Kg)
    Table 52. Middle East & Africa Deferiprone Sales by Country (2018-2023) & (Kg)
    Table 53. Middle East & Africa Deferiprone Sales Market Share by Country (2018-2023)
    Table 54. Middle East & Africa Deferiprone Revenue by Country (2018-2023) & ($ Millions)
    Table 55. Middle East & Africa Deferiprone Revenue Market Share by Country (2018-2023)
    Table 56. Middle East & Africa Deferiprone Sales by Type (2018-2023) & (Kg)
    Table 57. Middle East & Africa Deferiprone Sales by Application (2018-2023) & (Kg)
    Table 58. Key Market Drivers & Growth Opportunities of Deferiprone
    Table 59. Key Market Challenges & Risks of Deferiprone
    Table 60. Key Industry Trends of Deferiprone
    Table 61. Deferiprone Raw Material
    Table 62. Key Suppliers of Raw Materials
    Table 63. Deferiprone Distributors List
    Table 64. Deferiprone Customer List
    Table 65. Global Deferiprone Sales Forecast by Region (2024-2029) & (Kg)
    Table 66. Global Deferiprone Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 67. Americas Deferiprone Sales Forecast by Country (2024-2029) & (Kg)
    Table 68. Americas Deferiprone Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 69. APAC Deferiprone Sales Forecast by Region (2024-2029) & (Kg)
    Table 70. APAC Deferiprone Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 71. Europe Deferiprone Sales Forecast by Country (2024-2029) & (Kg)
    Table 72. Europe Deferiprone Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 73. Middle East & Africa Deferiprone Sales Forecast by Country (2024-2029) & (Kg)
    Table 74. Middle East & Africa Deferiprone Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 75. Global Deferiprone Sales Forecast by Type (2024-2029) & (Kg)
    Table 76. Global Deferiprone Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 77. Global Deferiprone Sales Forecast by Application (2024-2029) & (Kg)
    Table 78. Global Deferiprone Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 79. Apotex Basic Information, Deferiprone Manufacturing Base, Sales Area and Its Competitors
    Table 80. Apotex Deferiprone Product Portfolios and Specifications
    Table 81. Apotex Deferiprone Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2023)
    Table 82. Apotex Main Business
    Table 83. Apotex Latest Developments
    Table 84. Cipla Basic Information, Deferiprone Manufacturing Base, Sales Area and Its Competitors
    Table 85. Cipla Deferiprone Product Portfolios and Specifications
    Table 86. Cipla Deferiprone Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2023)
    Table 87. Cipla Main Business
    Table 88. Cipla Latest Developments
List of Figures
    Figure 1. Picture of Deferiprone
    Figure 2. Deferiprone Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Deferiprone Sales Growth Rate 2018-2029 (Kg)
    Figure 7. Global Deferiprone Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Deferiprone Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Tablet
    Figure 10. Product Picture of Oral Solution
    Figure 11. Product Picture of Capsule
    Figure 12. Global Deferiprone Sales Market Share by Type in 2022
    Figure 13. Global Deferiprone Revenue Market Share by Type (2018-2023)
    Figure 14. Deferiprone Consumed in Transfusional Iron Overload
    Figure 15. Global Deferiprone Market: Transfusional Iron Overload (2018-2023) & (Kg)
    Figure 16. Deferiprone Consumed in NTDT Caused Iron Overload
    Figure 17. Global Deferiprone Market: NTDT Caused Iron Overload (2018-2023) & (Kg)
    Figure 18. Global Deferiprone Sales Market Share by Application (2022)
    Figure 19. Global Deferiprone Revenue Market Share by Application in 2022
    Figure 20. Deferiprone Sales Market by Company in 2022 (Kg)
    Figure 21. Global Deferiprone Sales Market Share by Company in 2022
    Figure 22. Deferiprone Revenue Market by Company in 2022 ($ Million)
    Figure 23. Global Deferiprone Revenue Market Share by Company in 2022
    Figure 24. Global Deferiprone Sales Market Share by Geographic Region (2018-2023)
    Figure 25. Global Deferiprone Revenue Market Share by Geographic Region in 2022
    Figure 26. Americas Deferiprone Sales 2018-2023 (Kg)
    Figure 27. Americas Deferiprone Revenue 2018-2023 ($ Millions)
    Figure 28. APAC Deferiprone Sales 2018-2023 (Kg)
    Figure 29. APAC Deferiprone Revenue 2018-2023 ($ Millions)
    Figure 30. Europe Deferiprone Sales 2018-2023 (Kg)
    Figure 31. Europe Deferiprone Revenue 2018-2023 ($ Millions)
    Figure 32. Middle East & Africa Deferiprone Sales 2018-2023 (Kg)
    Figure 33. Middle East & Africa Deferiprone Revenue 2018-2023 ($ Millions)
    Figure 34. Americas Deferiprone Sales Market Share by Country in 2022
    Figure 35. Americas Deferiprone Revenue Market Share by Country in 2022
    Figure 36. Americas Deferiprone Sales Market Share by Type (2018-2023)
    Figure 37. Americas Deferiprone Sales Market Share by Application (2018-2023)
    Figure 38. United States Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 39. Canada Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Mexico Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Brazil Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 42. APAC Deferiprone Sales Market Share by Region in 2022
    Figure 43. APAC Deferiprone Revenue Market Share by Regions in 2022
    Figure 44. APAC Deferiprone Sales Market Share by Type (2018-2023)
    Figure 45. APAC Deferiprone Sales Market Share by Application (2018-2023)
    Figure 46. China Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 47. Japan Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 48. South Korea Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 49. Southeast Asia Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 50. India Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 51. Australia Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 52. China Taiwan Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 53. Europe Deferiprone Sales Market Share by Country in 2022
    Figure 54. Europe Deferiprone Revenue Market Share by Country in 2022
    Figure 55. Europe Deferiprone Sales Market Share by Type (2018-2023)
    Figure 56. Europe Deferiprone Sales Market Share by Application (2018-2023)
    Figure 57. Germany Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 58. France Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 59. UK Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 60. Italy Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Russia Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Middle East & Africa Deferiprone Sales Market Share by Country in 2022
    Figure 63. Middle East & Africa Deferiprone Revenue Market Share by Country in 2022
    Figure 64. Middle East & Africa Deferiprone Sales Market Share by Type (2018-2023)
    Figure 65. Middle East & Africa Deferiprone Sales Market Share by Application (2018-2023)
    Figure 66. Egypt Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 67. South Africa Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 68. Israel Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Turkey Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 70. GCC Country Deferiprone Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Manufacturing Cost Structure Analysis of Deferiprone in 2022
    Figure 72. Manufacturing Process Analysis of Deferiprone
    Figure 73. Industry Chain Structure of Deferiprone
    Figure 74. Channels of Distribution
    Figure 75. Global Deferiprone Sales Market Forecast by Region (2024-2029)
    Figure 76. Global Deferiprone Revenue Market Share Forecast by Region (2024-2029)
    Figure 77. Global Deferiprone Sales Market Share Forecast by Type (2024-2029)
    Figure 78. Global Deferiprone Revenue Market Share Forecast by Type (2024-2029)
    Figure 79. Global Deferiprone Sales Market Share Forecast by Application (2024-2029)
    Figure 80. Global Deferiprone Revenue Market Share Forecast by Application (2024-2029)

Apotex
Cipla

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape